drugset / Trial / NCT01655108

Efficacy and Safety of Mesotherapy With Minoxidil 0.5%/2ml for Androgenetic Alopecia in Female Patients

NCT01655108

Phase 3 Unknown 60 enrolled Brasilia University Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

This study aims to investigate the effectiveness and safety of mesotherapy for the treatment of female pattern alopecia. * Sixty female subjects between 18 and 65 years diagnosed with female pattern hair loss will undergo mesotherapy sessions weekly for ten weeks. * One group will receive 0.5%/2ml minoxidil application and a control group will receive application of placebo (saline 0.9%). * Biopsy of the scalp, trichogram and trichoscopy (Fotofinder) will be performed before and 08 weeks after treatment as a method objective evaluation of the response

Timeline

Start
2012-03
Primary completion
2013-10
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Minoxidil Small molecule 0.5 % Other
Comparator Minoxidil Small molecule 2 ml Other

Indications